Hexavalent vaccine

BIOLOGICAL3 trials

Sponsors

Sanofi Pasteur, a Sanofi Company, International Centre for Diarrhoeal Disease Research, Bangladesh, PATH

Conditions

Bacterial InfectionsMalaria (Plasmodium Falciparum)Malaria VaccinesNeisseria MeningitidisPolioVirus Diseases

Phase 2

Infant Malaria Vaccine Schedule Optimization

Active, not recruitingNCT06879327

PATHMalaria (Plasmodium Falciparum), Malaria Vaccines

Start: 2025-05-30End: 2027-10-18Updated: 2026-09-29

Phase 3

Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination

CompletedNCT01839175

Sanofi Pasteur, a Sanofi CompanyBacterial Infections, Neisseria Meningitidis, Virus Diseases

Start: 2013-04-30End: 2015-02-28Updated: 2017-09-11

Phase 4

Immunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV)

Not yet recruitingNCT06748612

International Centre for Diarrhoeal Disease Research, BangladeshPolio

Start: 2025-01-28End: 2027-12-30Target: 1190Updated: 2024-12-27

Related Papers

Concomitant administration of a fully liquid ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal ACWY conjugate vaccine in toddlers

Vaccine2018-11-2212 citations

Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infants.

2016-12-099 citations